Team:UC Chile/Biosafety

From 2013.igem.org

(Difference between revisions)
 
(8 intermediate revisions not shown)
Line 12: Line 12:
          
          
<body>
<body>
-
           <div id="hidden-links">Hidden<br>Links</div>
+
           <div id="hidden-links">Hidden<br>Links</div>        
           <div id="aux-igem"><a href="https://igem.org/Main_Page"><img src="https://static.igem.org/mediawiki/2013/archive/d/de/20130919203514%21IGEM_basic_Logo_stylized.png" id="igem-logo" border="0"></a></div>             
           <div id="aux-igem"><a href="https://igem.org/Main_Page"><img src="https://static.igem.org/mediawiki/2013/archive/d/de/20130919203514%21IGEM_basic_Logo_stylized.png" id="igem-logo" border="0"></a></div>             
           <div id="Header"><!--Inicio de Header-->
           <div id="Header"><!--Inicio de Header-->
             <img src="https://static.igem.org/mediawiki/2013/6/61/Team_UC_Chile_ALL_Header.png" usemap="#fotoMap" id="foto" border="0">
             <img src="https://static.igem.org/mediawiki/2013/6/61/Team_UC_Chile_ALL_Header.png" usemap="#fotoMap" id="foto" border="0">
             <map name="fotoMap">
             <map name="fotoMap">
-
                 <area shape="poly" coords="953,302,953,290,949,282,954,274,952,268,956,261,937,258,914,252,894,241,884,227,883,214,888,201,899,191,915,184,932,178,946,177,961,176,972,177,985,180,1000,186,1013,196,1023,206,1025,224,1019,237,1007,246,993,251,983,256,991,261,997,267,1003,266,999,276,1002,284,999,294,1002,303,993,307,984,315,978,316,968,318,966,311,958,307,953,302" href="https://2013.igem.org/Team:UC_Chile/The Game">
+
                 <area shape="rect" coords="61,167,153,213" href="Prueba link.html">
 +
                <area shape="rect" coords="34,207,62,243" href="Prueba link.html">
             </map>
             </map>
             <div id="MENU"><!--Inicio de MENU-->
             <div id="MENU"><!--Inicio de MENU-->
                 <img src="https://static.igem.org/mediawiki/2013/2/23/Team_UC_Chile_ALL_Circle.png">
                 <img src="https://static.igem.org/mediawiki/2013/2/23/Team_UC_Chile_ALL_Circle.png">
                 <div class="new_menu"><!--Inicio de new Menu-->
                 <div class="new_menu"><!--Inicio de new Menu-->
-
                     <div class="h1 hexa " onclick="aux(1)">
+
                     <div class="h1 hexa" onclick="aux(1)">
                         <div class="rec d"></div>
                         <div class="rec d"></div>
                         <div class="rec d d2"></div>
                         <div class="rec d d2"></div>
                         <div class="rec d d3"></div>
                         <div class="rec d d3"></div>
-
                         <div class="text">Team</div>
+
                         <div class="text">Results</div>
-
                         <ul class="sub oculto">                            
+
                         <ul class="sub oculto">
-
                             <li class="pos1 sub_item oculto">Team Members<a href="https://2013.igem.org/Team:UC_Chile/Team Members"></a></li>
+
                             <li class="pos1 sub_item oculto">BioBricks<a href="https://2013.igem.org/Team:UC_Chile/BioBricks"></a></li>
-
                             <li class="pos2 sub_item oculto">PSB Lab<a href="https://2013.igem.org/Team:UC_Chile/PSBL Lab"></a></li>
+
                             <li class="pos2 sub_item oculto">Mathematical Model<a href="https://2013.igem.org/Team:UC_Chile/Mathematical Model"></a></li>
-
                             <li class="pos3 sub_item oculto">Photo gallery<a href="https://2013.igem.org/Team:UC_Chile/Photo Gallery"></a></li>
+
                             <li class="pos3 sub_item oculto">Wet Lab<a href="https://2013.igem.org/Team:UC_Chile/Wet Lab"></a></li>                          
                         </ul>
                         </ul>
                     </div>
                     </div>
-
                     <div class="h2 hexa " onclick="aux(2)">
+
                     <div class="h2 hexa" onclick="aux(2)">
                         <div class="rec d"></div>
                         <div class="rec d"></div>
                         <div class="rec d d2"></div>
                         <div class="rec d d2"></div>
                         <div class="rec d d3"></div>
                         <div class="rec d d3"></div>
-
                         <div class="text">Human<br>Practices</div>
+
                         <div class="text">Team</div>
                         <ul class="sub oculto">
                         <ul class="sub oculto">
-
                             <li class="pos1 sub_item oculto">Home<a href="https://2013.igem.org/Team:UC_Chile/Human Practices"></a></li>                          
+
                             <li class="pos1 sub_item oculto">Team Members<a href="https://2013.igem.org/Team:UC_Chile/Team Members"></a></li>
 +
                            <li class="pos2 sub_item oculto">PSB Lab<a href="https://2013.igem.org/Team:UC_Chile/PSBL Lab"></a></li>
 +
                            <li class="pos3 sub_item oculto">Photo gallery<a href="https://2013.igem.org/Team:UC_Chile/Photo Gallery"></a></li>
                         </ul>
                         </ul>
                     </div>
                     </div>
Line 46: Line 49:
                         <div class="rec d d2"></div>
                         <div class="rec d d2"></div>
                         <div class="rec d d3"></div>
                         <div class="rec d d3"></div>
-
                         <div class="text">More</div>
+
                         <div class="text">Human<br>Practices</div>
                         <ul class="sub oculto">
                         <ul class="sub oculto">
-
                             <li class="pos1 sub_item oculto">Collaborations<a href="https://2013.igem.org/Team:UC_Chile/Collaborations"></a></li>
+
                             <li class="pos1 sub_item oculto">Home<a href="https://2013.igem.org/Team:UC_Chile/Human Practices"></a></li>
-
                             <li class="pos2 sub_item oculto">Judging Criteria<a href="https://2013.igem.org/Team:UC_Chile/Judging Criteria"></a></li>
+
                             <li class="pos2 sub_item oculto">Synbio web<a href="https://2013.igem.org/Team:UC_Chile/Synbio web"></a></li>
-
                            <li class="pos3 sub_item oculto">Acknowledgments<a href="https://2013.igem.org/Team:UC_Chile/Acknowledgments"></a></li>
+
                         </ul>
                         </ul>
-
                     </div>                  
+
                     </div>
                     <div class="h4 hexa sele" onclick="aux(4)">
                     <div class="h4 hexa sele" onclick="aux(4)">
                         <div class="rec d"></div>
                         <div class="rec d"></div>
                         <div class="rec d d2"></div>
                         <div class="rec d d2"></div>
                         <div class="rec d d3"></div>
                         <div class="rec d d3"></div>
-
                         <div class="text">Project</div>
+
                         <div class="text">More</div>
                         <ul class="sub ">
                         <ul class="sub ">
-
                             <li class="pos1 sub_item ">Whateversisoma<a href="https://2013.igem.org/Team:UC_Chile/Whateversisome"></a></li>
+
                             <li class="pos1 sub_item ">Acknowledgments<a href="https://2013.igem.org/Team:UC_Chile/Acknowledgments"></a></li>
-
                             <li class="pos2 sub_item ">Biobricks<a href="https://2013.igem.org/Team:UC_Chile/Biobricks"></a></li>
+
                             <li class="pos2 sub_item ">Biosafety<a href="https://2013.igem.org/Team:UC_Chile/Biosafety"></a></li>
-
                            <li class="pos3 sub_item ">Biosafety<a href="https://2013.igem.org/Team:UC_Chile/Biosafety"></a></li>
+
-
                            <li class="pos4 sub_item ">Side project<a href="https://2013.igem.org/Team:UC_Chile/Side Project"></a></li>
+
                         </ul>
                         </ul>
-
                     </div>
+
                     </div>                                      
-
                     <div class="h5 hexa " onclick="aux(5)">
+
                     <div class="h5 hexa" onclick="aux(5)">
                         <div class="rec d"></div>
                         <div class="rec d"></div>
                         <div class="rec d d2"></div>
                         <div class="rec d d2"></div>
                         <div class="rec d d3"></div>
                         <div class="rec d d3"></div>
-
                         <div class="text">Methodology</div>
+
                         <div class="text">Project</div>
                         <ul class="sub oculto">
                         <ul class="sub oculto">
-
                             <li class="pos1 sub_item oculto">Protocols<a href="https://2013.igem.org/Team:UC_Chile/Protocols"></a></li>
+
                             <li class="pos1 sub_item oculto">Description<a href="https://2013.igem.org/Team:UC_Chile/Description"></a></li>
-
                             <li class="pos2 sub_item oculto">Lab Notebook<a href="https://2013.igem.org/Team:UC_Chile/Lab NoteBook"></a></li>
+
                             <li class="pos2 sub_item oculto">Formation<a href="https://2013.igem.org/Team:UC_Chile/Formation"></a></li>
 +
                            <li class="pos3 sub_item oculto">Targeting<a href="https://2013.igem.org/Team:UC_Chile/Targeting"></a></li>
 +
                            <li class="pos4 sub_item oculto">Purification<a href="https://2013.igem.org/Team:UC_Chile/Purification"></a></li>
 +
                            <li class="pos5 sub_item oculto">Disruption<a href="https://2013.igem.org/Team:UC_Chile/Disruption"></a></li>
 +
                            <li class="pos5 sub_item oculto">In vitro Channeling<a href="https://2013.igem.org/Team:UC_Chile/In vitro Channeling"></a></li>
                         </ul>
                         </ul>
-
                        </div>
+
                    </div>                  
-
                     <div class="h6 hexa " onclick="aux(6)">
+
                     <div class="h6 hexa" onclick="aux(6)">
                         <div class="rec d"></div>
                         <div class="rec d"></div>
                         <div class="rec d d2"></div>
                         <div class="rec d d2"></div>
                         <div class="rec d d3"></div>
                         <div class="rec d d3"></div>
-
                         <div class="text">Modelling</div>
+
                         <div class="text">Methodology</div>
                         <ul class="sub oculto">
                         <ul class="sub oculto">
-
                             <li class="pos1 sub_item oculto">Mathematical Model<a href="https://2013.igem.org/Team:UC_Chile/Mathematical Model"></a></li>
+
                             <li class="pos1 sub_item oculto">Lab Notebook<a href="https://2013.igem.org/Team:UC_Chile/Lab NoteBook"></a></li>
-
                             <li class="pos2 sub_item oculto">Software<a href="https://2013.igem.org/Team:UC_Chile/Software"></a></li>
+
                             <li class="pos2 sub_item oculto">Protocols<a href="https://2013.igem.org/Team:UC_Chile/Protocols"></a></li>
                         </ul>
                         </ul>
-
                     </div>
+
                     </div>                                
-
                     <div class="h7 hexa" onclick="aux(7)">
+
                     <div class="h7 hexa " onclick="location.href='https://2013.igem.org/Team:UC_Chile/Overview'">
                         <div class="rec d"></div>
                         <div class="rec d"></div>
                         <div class="rec d d2"></div>
                         <div class="rec d d2"></div>
Line 92: Line 96:
                         <ul class="sub oculto">
                         <ul class="sub oculto">
                             <li class="pos1 sub_item oculto">Overview<a href="https://2013.igem.org/Team:UC_Chile/Overview"></a></li>
                             <li class="pos1 sub_item oculto">Overview<a href="https://2013.igem.org/Team:UC_Chile/Overview"></a></li>
-
                            <li class="pos2 sub_item oculto">Achievements<a href="https://2013.igem.org/Team:UC_Chile/Achievements"></a></li>
 
                         </ul>
                         </ul>
-
                     </div>
+
                     </div>    
                 </div><!--Fin de new Menu-->
                 </div><!--Fin de new Menu-->
-
             </div><!--Fin de MENU-->          
+
             </div><!--Fin de MENU-->  
         </div><!--Fin de Header-->
         </div><!--Fin de Header-->
         <div id="Container"><!--Inicio de Contenedor-->
         <div id="Container"><!--Inicio de Contenedor-->
Line 109: Line 112:
<div class="normal-text">
<div class="normal-text">
<h4>1. Would any of your project ideas raise safety issues in terms of researcher, public safety or environmental safety?</h4>
<h4>1. Would any of your project ideas raise safety issues in terms of researcher, public safety or environmental safety?</h4>
-
Our project proposes the utilization of proteinaceous microcompartments as a new in vitro technology for science, so the idea itself, being limited to the use only within a laboratory, would not generate a public or environmental hazard.<br>
+
Our project proposes the utilization of protein-based micro compartments as a new in vitro technology for science. The idea is going to be developed at the laboratory with the proper biosafety conditions of handle and disposal of reagents and biological material. For those reasons it does not represent any public and/or environmental biohazard.<br><br>
-
Also, our project only involves type 1-risk microorganisms (Top10, BL21, and Dh5α strains that are E. Coli K12 derivatives) according to the Risk Group Table and the World Health Organization Laboratory Biosafety Manual <a href="#Referencias">(1,2)</a>; and the BioBricks or genes used in this chassis don’t have any potential biological hazard. The only one is the utilization of antibiotic resistance as selection markers. In our laboratory there are protocols established by the National Commission for Scientific and Technological Research (CONICYT) to disposed any biologic material and different reagents with environmental toxicity, they are discarded after a number of decontamination processes like autoclaving, chemical disinfection, and incineration <a href="#Referencias">(3)</a>. Therefore, the environment shouldn’t be affected by our work.
+
In addition, our project involves the use of microorganisms with a biosafety level 1 (Top10, BL21, and Dh5α strains that are E. Coli K12 derivatives) according to the Risk Group Table and the World Health Organization Laboratory Biosafety Manual <a href="#Referencias">(1,2)</a>. Also, the BioBricks or genes used in this chassis do not show any potential biological hazard. The utilization of antibiotic resistance as selection markers could be the only potential bio risk.<br><br>
 +
Our laboratory has a well documented and stabilized protocols to dispose any biological material and to discard different reagents with environmental toxicity. The reagents and others are discarded after a particular number of decontamination processes as autoclaving, chemical disinfection, and incineration <a href="#Referencias">(3)</a>. Therefore, the environment should not be affected by our work. This guideline of biohazard disposal is  part of the regulation from the National Commission for Scientific and Technological Research (CONICYT) in Chile.<br><br>
</div>
</div>
<!--Fin texto normal-->
<!--Fin texto normal-->
Line 117: Line 121:
<div class="normal-text">
<div class="normal-text">
<h4>2. Do any of the new BioBrick parts (or devices) that you made this year raise safety issues?</h4>
<h4>2. Do any of the new BioBrick parts (or devices) that you made this year raise safety issues?</h4>
-
As described above, the bricks or genes used in this project don't have any potential biological hazard.
+
As we described above, the biobricks and/or genes used in this project do not represent any potential biological hazard.
</div>
</div>
<!--Fin texto normal-->
<!--Fin texto normal-->
Line 124: Line 128:
<div class="normal-text">
<div class="normal-text">
<h4>3. Is there a local biosafety group, committee, or review board at your institution?</h4>
<h4>3. Is there a local biosafety group, committee, or review board at your institution?</h4>
-
Yes, The Committee of Bioethics and Biosafety of the Biological Sciences Faculty of Pontificia Universidad Católica of Chile, this committee is responsible for ensuring good practices in the laboratories of our university, and this is achieved through the regulations provided by the Chilean Comission of Scientific and Technological Research (CONICYT).
+
Yes, there is. The Committee of Bioethics and Biosafety of the Biological Sciences part of the Faculty of Pontificia Universidad Católica of Chile. This committee is responsible for ensuring good practices in the laboratories in our university and also, this is achieved through the regulations provided by the Chilean Comission of Scientific and Technological Research (CONICYT).
</div>
</div>
<!--Fin texto normal-->
<!--Fin texto normal-->
Line 131: Line 135:
<div class="normal-text">
<div class="normal-text">
<h4>4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?</h4>
<h4>4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?</h4>
-
The main use we want to give our project is to generate metabolic reactions within the BMCs, and thus decouple metabolic pathways from organisms and bring them to an in vitro level. This will help to solve biosafety concerns and problems. For example, not using any kind of microorganisms (MO) for those processes will decrease the use of selection markers such as antibiotic resistance cassettes and the lateral gene transfer would be much more difficult; or very important points in the global discussion on GMOs such as the effect of synthetic MO in the native organisms could be avoided. With this, we hope to reduce the use of living organisms and all complications in terms of biosafety that entails.<br>
+
 
-
Yet another important feature that our project has is an autolysis system that meets two very important functions, helping the extraction of BMCs and safely eliminate the microorganisms that we are using, thus making sure that will not be dispersed to the environment.<br>
+
The main use we want to give to our project is to generate metabolic reactions within the BMCs, and thus decouple metabolic pathways from organisms and bring them to an in vitro level. This pipeline will help to solve biosafety concerns and problems. For example, not using any kind of microorganisms (MO) for those processes will decrease the use of selection markers such as antibiotic resistance cassettes and the lateral gene transfer would be much more difficult.  Additionally, another important point in the global discussion on GMOs such as the effect of synthetic MO in the native organisms could be avoided. As we describe above, we hope to reduce the use of living organisms and all complications in terms of biosafety that entails.<br><br>
-
Click <a href="https://2013.igem.org/Team:UC_Chile/Disruption">here</a> for more information about the autolysis device<br>
+
Our project has another relevant feature: an autolysis system. It meets two very important functions, one of them is helping the extraction of BMCs and the second one is that it is safety way to eliminate the microorganisms that we are using. With those functions, we are making sure that it will not be dispersed to the environment.<br><br>
-
Other idea that came to our minds was the generation of bricks with removable resistance. This could be achieved by constructing a system using invertases from phages. Thus, we would generate deletions in the regions with the resistance, and later confer a new marker, which in this case could be a fluorophore or a chromophore.<br>
+
Click <a href="https://2013.igem.org/Team:UC_Chile/Disruption">here</a> for more information about the autolysis device.<br><br>  
-
This way, one of the biggest drawbacks of Synthetic Biology could be avoided, which is to make laboratory strains of bacteria resistance to antibiotics indiscriminately, creating potential environmental risks by transferring these resistances to pathogenic bacteria or other unwanted organism.<br>
+
  Other idea that came to our minds in a certain point of this project development is the generation of bricks with removable resistance. This could be achieved using an invertases-based system in which the invertases come from phages. Thus, we would generate deletions in the DNA regions with the resistance and later switch the resistance locus with  a new marker like a a fluorophore or chromophore.<br><br>
-
This idea was inspired by the somatic recombination of the immune system, where RAG-1 and RAG-2 recognize specific segments called Recombination Signal Sequences (RSSs), where complex of proteins can invert or remove segments of DNA from the genome depending on the position of the RSSs. The whole process is performed in order to generate diversity in the generation of antibodies.<br>  
+
Through this simple strategy, Synthetic Biology could face one the main drawbacks of not-target strains with undesirable antibiotic resistance. It is well known and documented that some laboratory bacterial strains are antibiotic resistance and they represent environmental risks because they could transfer the resistance to other pathogenic bacteria or other unwanted organism. <br><br>
 +
Our idea is inspired by the somatic recombination of the immune system. This immune strategy is based in the principle where RAG-1 and RAG-2 recognize specific segments called Recombination Signal Sequences (RSSs). The complex of proteins can invert or remove segments of DNA from the genome depending on the position of the RSSs. The whole process is performed in order to generate diversity in the generation of antibodies.<br>
<!--Inicio de Imagen con legenda(1)-->
<!--Inicio de Imagen con legenda(1)-->
<div class="img_center_legend">
<div class="img_center_legend">
     <img src="https://static.igem.org/mediawiki/2013/0/07/Team_UC_Chile_Biosafety_1.png">
     <img src="https://static.igem.org/mediawiki/2013/0/07/Team_UC_Chile_Biosafety_1.png">
-
     <div class="legend">Inversion and deletion depending on the orientation of the specific sites <a href="#Referencias">(4)</a></div>
+
     <div class="legend">Image of the two options in Site-specific recombination: Inversion and Deletion.<a href="#Referencias">(4)</a></div>
</div>
</div>
<!--Fin de Imagen con legenda-->
<!--Fin de Imagen con legenda-->
-
Image of the two options in Site-specific recombination: Inversion and Deletion.<br>
+
In our journey to find proteins with new features, we found the Marburg project in 2012(4). This project proposes the use of an invertase from Phage Mu to generate random deletions and thus create diverse phenotypes. The invertase in the phage recognized the GL (gixL) and GR (gixR) sites, inverting the called G-segment that contains two genes in which those have been expressed by the same promoter but with a different conformations.<br>
-
Looking for proteins with similar characteristics, we found the Marburg 2012's project <a href="#Referencias">(4)</a>. That project uses an invertase from Phage Mu to generate random deletions and thus create diverse phenotypes. The invertase in the phage works recognizing the GL (gixL) and GR (gixR) sites, inverting the called G-segment that contains two genes, which are expressed by the same promoter but in different conformations.<br>
+
<!--Inicio de Imagen con legenda(2)-->
<!--Inicio de Imagen con legenda(2)-->
<div class="img_center_legend">
<div class="img_center_legend">
Line 151: Line 155:
</div>
</div>
<!--Fin de Imagen con legenda-->
<!--Fin de Imagen con legenda-->
-
G-Segment of phage Mu, with the flanking sites GL and GR.<br>
+
In simple words, our idea is looking forward to a have constitutive expression of a resistance cassette to use it as a selection marker in transformations but the design of the construct implies that the resistance in the CDS will be flanked by Gl and Gr. Those regions are going to be recognized by the invertase enzymes. Therefore, when the induction of the invertase has taken place it will remove that undesirable region from the plasmid and the resistant bacteria will be converted to non-resistant bacteria expressing another reporter protein which represent a less biosafety issue like a fluorophore.<br><br>
-
In basic terms, our idea is to have constitutive expression of the resistance cassette to use it as a selection marker in transformations, but the design of the construct implies that the resistance's CDS will be flanked by Gl and Gr, regions recognized by the invertase. So, when the induction of the invertase has taken place, it will remove that region of the plasmid, and the resistant bacteria will be converted to non-resistant bacteria with expression of another reporter protein with less biosafety problems, like a fluorophore.<br>
+
The idea is presented in the following diagram.<br>
The idea is presented in the following diagram.<br>
<!--Inicio de Imagen con legenda(3)-->
<!--Inicio de Imagen con legenda(3)-->
<div class="img_center_legend">
<div class="img_center_legend">
     <img src="https://static.igem.org/mediawiki/2013/4/4f/Team_UC_Chile_Biosafety_3.jpg">
     <img src="https://static.igem.org/mediawiki/2013/4/4f/Team_UC_Chile_Biosafety_3.jpg">
-
     <div class="legend">Diagram of ours hypotetical BioBrick</div>
+
    <img src="https://static.igem.org/mediawiki/2013/6/62/Team_UC_Chile_Biosafety_4.jpg">
 +
     <div class="legend">Diagram of ours hypotetical BioBrick, with and without induction.</div>
</div>
</div>
<!--Fin de Imagen con legenda-->
<!--Fin de Imagen con legenda-->
</div>
</div>
<!--Fin texto normal-->
<!--Fin texto normal-->
-
 
<!--Inicio REferencias-->
<!--Inicio REferencias-->
<div class="Referencias">
<div class="Referencias">
-
     <a name="Referencias">
+
     <a name="Referencias"></a>
-
     <h6><b>References:</b></h6>
+
     <b>References:</b>
     <ul>
     <ul>
-
         <li><span>World Health Organization (WHO), 2004. Laboratory Biosafety Manual. Geneva: World Health Organization.Pp.102. Available in:</span><br><a href="http://www.who.int/csr/resources/publications/biosafety/Biosafety7.pdf">http://www.who.int/csr/resources/publications/biosafety/Biosafety7.pdf</a></li>
+
         <li><span>1. World Health Organization (WHO). (2004). Laboratory Biosafety Manual. Geneva: World Health Organization.Pp.102. Available in:</span><br><a href="http://www.who.int/csr/resources/publications/biosafety/Biosafety7.pdf">http://www.who.int/csr/resources/publications/biosafety/Biosafety7.pdf</a></li>
-
         <li><span>IGEM, Safety.[internet principal page]. United States. Risk Group Table. [consult day: sep 5, 2013]. Available in:</span><br><a href="https://2013.igem.org/Safety/Risk_Group_Table">https://2013.igem.org/Safety/Risk_Group_Table</a></li>
+
         <li><span>2. IGEM, Safety. (2013).[internet principal page]. United States. Risk Group Table. Retrieved: September 2013, from:</span><br><a href="https://2013.igem.org/Safety/Risk_Group_Table">https://2013.igem.org/Safety/Risk_Group_Table</a></li>
-
         <li><span>Allende J et al, 2008. Manual De Normas De Bioseguridad. Chile: Fondecyt-Conicyt.Pp.27-29. Available in:</span><br><a href="http://www.conicyt.cl/fondecyt/files/2012/09/articles-30555_recurso_1.pdf">http://www.conicyt.cl/fondecyt/files/2012/09/articles-30555_recurso_1.pdf</a></li>      
+
         <li><span>3. Allende J et al. (2008). Manual De Normas De Bioseguridad. Chile: Fondecyt-Conicyt.Pp.27-29. Available in:</span><br><a href="http://www.conicyt.cl/fondecyt/files/2012/09/articles-30555_recurso_1.pdf">http://www.conicyt.cl/fondecyt/files/2012/09/articles-30555_recurso_1.pdf</a></li>
-
         <li><span>IGEM, Team:Marburg_SYNMIKRO.[internet principal page]. United States. Project. [consult day: sep 5, 2013]. Available in:</span><br><a href="https://2012.igem.org/Team:Marburg_SYNMIKRO/Project">https://2012.igem.org/Team:Marburg_SYNMIKRO/Project</a></li>
+
         <li><span>4. IGEM, Team:Marburg_SYNMIKRO. (2012).[internet principal page]. United States. Project. Retrieved: September 2013, from:</span><br><a href="https://2012.igem.org/Team:Marburg_SYNMIKRO/Project">https://2012.igem.org/Team:Marburg_SYNMIKRO/Project</a></li>
     </ul>
     </ul>
</div>
</div>
-
<!--Fin de Referencias-->
+
<!--Fin de Referencias-->                  
         </div><!--Fin de Contenedor-->         
         </div><!--Fin de Contenedor-->         
</body>         
</body>         
</html>
</html>

Latest revision as of 01:52, 13 October 2013

Wiki-IGEM

Biosafety

1. Would any of your project ideas raise safety issues in terms of researcher, public safety or environmental safety?

Our project proposes the utilization of protein-based micro compartments as a new in vitro technology for science. The idea is going to be developed at the laboratory with the proper biosafety conditions of handle and disposal of reagents and biological material. For those reasons it does not represent any public and/or environmental biohazard.

In addition, our project involves the use of microorganisms with a biosafety level 1 (Top10, BL21, and Dh5α strains that are E. Coli K12 derivatives) according to the Risk Group Table and the World Health Organization Laboratory Biosafety Manual (1,2). Also, the BioBricks or genes used in this chassis do not show any potential biological hazard. The utilization of antibiotic resistance as selection markers could be the only potential bio risk.

Our laboratory has a well documented and stabilized protocols to dispose any biological material and to discard different reagents with environmental toxicity. The reagents and others are discarded after a particular number of decontamination processes as autoclaving, chemical disinfection, and incineration (3). Therefore, the environment should not be affected by our work. This guideline of biohazard disposal is part of the regulation from the National Commission for Scientific and Technological Research (CONICYT) in Chile.

2. Do any of the new BioBrick parts (or devices) that you made this year raise safety issues?

As we described above, the biobricks and/or genes used in this project do not represent any potential biological hazard.

3. Is there a local biosafety group, committee, or review board at your institution?

Yes, there is. The Committee of Bioethics and Biosafety of the Biological Sciences part of the Faculty of Pontificia Universidad Católica of Chile. This committee is responsible for ensuring good practices in the laboratories in our university and also, this is achieved through the regulations provided by the Chilean Comission of Scientific and Technological Research (CONICYT).

4. Do you have any other ideas how to deal with safety issues that could be useful for future iGEM competitions? How could parts, devices and systems be made even safer through biosafety engineering?

The main use we want to give to our project is to generate metabolic reactions within the BMCs, and thus decouple metabolic pathways from organisms and bring them to an in vitro level. This pipeline will help to solve biosafety concerns and problems. For example, not using any kind of microorganisms (MO) for those processes will decrease the use of selection markers such as antibiotic resistance cassettes and the lateral gene transfer would be much more difficult. Additionally, another important point in the global discussion on GMOs such as the effect of synthetic MO in the native organisms could be avoided. As we describe above, we hope to reduce the use of living organisms and all complications in terms of biosafety that entails.

Our project has another relevant feature: an autolysis system. It meets two very important functions, one of them is helping the extraction of BMCs and the second one is that it is safety way to eliminate the microorganisms that we are using. With those functions, we are making sure that it will not be dispersed to the environment.

Click here for more information about the autolysis device.

Other idea that came to our minds in a certain point of this project development is the generation of bricks with removable resistance. This could be achieved using an invertases-based system in which the invertases come from phages. Thus, we would generate deletions in the DNA regions with the resistance and later switch the resistance locus with a new marker like a a fluorophore or chromophore.

Through this simple strategy, Synthetic Biology could face one the main drawbacks of not-target strains with undesirable antibiotic resistance. It is well known and documented that some laboratory bacterial strains are antibiotic resistance and they represent environmental risks because they could transfer the resistance to other pathogenic bacteria or other unwanted organism.

Our idea is inspired by the somatic recombination of the immune system. This immune strategy is based in the principle where RAG-1 and RAG-2 recognize specific segments called Recombination Signal Sequences (RSSs). The complex of proteins can invert or remove segments of DNA from the genome depending on the position of the RSSs. The whole process is performed in order to generate diversity in the generation of antibodies.
Image of the two options in Site-specific recombination: Inversion and Deletion.(4)
In our journey to find proteins with new features, we found the Marburg project in 2012(4). This project proposes the use of an invertase from Phage Mu to generate random deletions and thus create diverse phenotypes. The invertase in the phage recognized the GL (gixL) and GR (gixR) sites, inverting the called G-segment that contains two genes in which those have been expressed by the same promoter but with a different conformations.
The invertible G-segment of bacteriophage Mu (4)
In simple words, our idea is looking forward to a have constitutive expression of a resistance cassette to use it as a selection marker in transformations but the design of the construct implies that the resistance in the CDS will be flanked by Gl and Gr. Those regions are going to be recognized by the invertase enzymes. Therefore, when the induction of the invertase has taken place it will remove that undesirable region from the plasmid and the resistant bacteria will be converted to non-resistant bacteria expressing another reporter protein which represent a less biosafety issue like a fluorophore.

The idea is presented in the following diagram.
Diagram of ours hypotetical BioBrick, with and without induction.
References: